News
Aphena Relocates and Expands Chocolated Manufacturing Operations to Fourfold Increase in Production Capacity
Aphena Pharma Solutions is pleased to announce the relocation and major expansion of our chocolated pharmaceutical manufacturing operations. Offerings include brand-equivalent formulations of senna OTC laxatives (compare to Ex-Lax ®) marketed as private-label products. All production has been...
News
Kyowa Hakko Kirin Completed of Construction for the Biopharmaceutical API Manufacturing Facility in the Takasaki Plant
Kyowa Hakko Kirin Co Ltd has completed the construction of the HB6 Plant in the Takasaki Plant (Takasaki city, Gunma, Plant Manager: Hitoshi Arai) in August 2016. The new HB6 facility is equipped with one of the largest bioreactors...
News
Mylan Launches Generic Dexedrine® Capsules
Mylan N.V. announced the U.S. launch of Dextroamphetamine Sulfate Extended-release Capsules, 5 mg, 10 mg, and 15 mg, a generic version of Amedra Pharmaceuticals LLC's Dexedrine®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for...
News
Servier invests in bioproduction in France
Servier announces the launch of a bioproduction programme at its site in Gidy. First research batches in 2019 and first clinical batches in 2020. Today, approximately 50% of the new anticancer treatments originate from biotechnologies, and the partnerships...
News
Sumitomo Dainippon Pharma Listed in FTSE4Good Index Series of Socially Responsible Investment for the 14th Consecutive Year
Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada) has been selected for inclusion in the FTSE4Good Index Series of socially responsible investment (SRI).*1 The company has now been listed for 14 years in succession, starting...
News
Allergan Receives Positive Opinion For Truberzi® (Eluxadoline) For Treatment Of Irritable Bowel Syndrome With Diarrhoea (IBS-D) In Adults
Allergan plc a leading global pharmaceutical company, announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a Positive Opinion for TRUBERZI® (eluxadoline) in the European Union.4 TRUBERZI® is an oral medication that relieves the main...
News
Open House Marchesini Group: the countdown to the opening of the biggest thermoforming hub in Italy has begun
The Thermoforming Hub Open House of Marchesini Group is one of the most long-awaited events of next Autumn for the Italian pharmaceutical industry. The event starts officially on 15th October when authorities, citizens and all of the employees of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















